These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17380790)

  • 1. Poly (ADP-ribose) polymerase activation and circulatory shock.
    Szabó C
    Novartis Found Symp; 2007; 280():92-103; discussion 103-7, 160-4. PubMed ID: 17380790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock.
    Evgenov OV; Liaudet L
    Curr Vasc Pharmacol; 2005 Jul; 3(3):293-9. PubMed ID: 16026325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of poly(adenosine 5'-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock.
    Soriano FG; Nogueira AC; Caldini EG; Lins MH; Teixeira AC; Cappi SB; Lotufo PA; Bernik MM; Zsengellér Z; Chen M; Szabó C
    Crit Care Med; 2006 Apr; 34(4):1073-9. PubMed ID: 16484919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
    Virág L
    Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
    Pacher P; Szabó C
    Cardiovasc Drug Rev; 2007; 25(3):235-60. PubMed ID: 17919258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.
    Luo X; Kraus WL
    Genes Dev; 2012 Mar; 26(5):417-32. PubMed ID: 22391446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury.
    Szabó G; Bährle S
    Curr Vasc Pharmacol; 2005 Jul; 3(3):215-20. PubMed ID: 16026318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) polymerase activation by reactive nitrogen species--relevance for the pathogenesis of inflammation.
    Szabó C
    Nitric Oxide; 2006 Mar; 14(2):169-79. PubMed ID: 16111903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
    Komjáti K; Besson VC; Szabó C
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions.
    Islam BU; Habib S; Ali SA; Moinuddin ; Ali A
    Cardiovasc Toxicol; 2017 Oct; 17(4):373-383. PubMed ID: 27990620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.
    Kiss L; Szabó C
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():29-37. PubMed ID: 15962096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation.
    Aldinucci A; Gerlini G; Fossati S; Cipriani G; Ballerini C; Biagioli T; Pimpinelli N; Borgognoni L; Massacesi L; Moroni F; Chiarugi A
    J Immunol; 2007 Jul; 179(1):305-12. PubMed ID: 17579050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribose) polymerase inhibitors.
    Southan GJ; Szabó C
    Curr Med Chem; 2003 Feb; 10(4):321-40. PubMed ID: 12570705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
    Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
    Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress.
    Oláh G; Szczesny B; Brunyánszki A; López-García IA; Gerö D; Radák Z; Szabo C
    PLoS One; 2015; 10(7):e0134227. PubMed ID: 26218895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
    Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
    J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iNOS induction and PARP-1 activation in human atherosclerotic lesions: an immunohistochemical and ultrastructural approach.
    Perrotta I; Brunelli E; Sciangula A; Conforti F; Perrotta E; Tripepi S; Donato G; Cassese M
    Cardiovasc Pathol; 2011; 20(4):195-203. PubMed ID: 20619687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation.
    Qin WD; Wei SJ; Wang XP; Wang J; Wang WK; Liu F; Gong L; Yan F; Zhang Y; Zhang M
    Biochim Biophys Acta; 2013 Jan; 1833(1):59-68. PubMed ID: 23085506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice.
    Soriano FG; Liaudet L; Szabó E; Virág L; Mabley JG; Pacher P; Szabó C
    Shock; 2002 Apr; 17(4):286-92. PubMed ID: 11954828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.